Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks

  1. Hui Zhao
  2. Bernard Thienpont
  3. Betül T Yesilyurt
  4. Matthieu Moisse
  5. Joke Reumers
  6. Lieve Coenegrachts
  7. Xavier Sagaert
  8. Stefanie Schrauwen
  9. Dominiek Smeets
  10. Gert Matthijs
  11. Stein Aerts
  12. Jan Cools
  13. Alex Metcalf
  14. Amanda Spurdle
  15. ANECS
  16. Frederic Amant
  17. Diether Lambrechts  Is a corresponding author
  1. VIB Vesalius Research Center, KU Leuven, Belgium
  2. University Hospital Gasthuisberg, Belgium
  3. KU Leuven, Belgium
  4. University of Leuven, Belgium
  5. Queensland Institute of Medical Research, Australia
  6. PO Royal Brisbane Hospital, Australia

Abstract

DNA replication errors that persist as mismatch mutations make up the molecular fingerprint of mismatch repair (MMR)-deficient tumors and convey them with resistance to standard therapy. Using whole-genome and -exome sequencing, we here confirm an MMR-deficient mutation signature that is distinct from other tumor genomes, but surprisingly similar to germ-line DNA, confirming that a substantial fraction of human genetic variation arises through mutations escaping MMR. Moreover, we identify a large set of recurrent indels that may serve to detect microsatellite instability (MSI). Indeed, using endometrial tumors with immunohistochemically-proven MMR deficiency, we optimize a novel marker set capable of detecting MSI and show it to have greater specificity and selectivity than standard MSI tests. Additionally, we show that recurrent indels are enriched for the 'DNA double-strand break repair by homologous recombination' pathway. Consequently, DSB repair is reduced in MMR-deficient tumors, triggering a dose-dependent sensitivity of MMR-deficient tumor cultures to DSB inducers.

Article and author information

Author details

  1. Hui Zhao

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  2. Bernard Thienpont

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  3. Betül T Yesilyurt

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  4. Matthieu Moisse

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  5. Joke Reumers

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  6. Lieve Coenegrachts

    University Hospital Gasthuisberg, Leuven, Belgium
    Competing interests
    No competing interests declared.
  7. Xavier Sagaert

    University Hospital Gasthuisberg, Leuven, Belgium
    Competing interests
    No competing interests declared.
  8. Stefanie Schrauwen

    University Hospital Gasthuisberg, Leuven, Belgium
    Competing interests
    No competing interests declared.
  9. Dominiek Smeets

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  10. Gert Matthijs

    KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  11. Stein Aerts

    University of Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  12. Jan Cools

    KU Leuven, Leuven, Belgium
    Competing interests
    No competing interests declared.
  13. Alex Metcalf

    Queensland Institute of Medical Research, Brisbane, Australia
    Competing interests
    No competing interests declared.
  14. Amanda Spurdle

    Queensland Institute of Medical Research, Brisbane, Australia
    Competing interests
    No competing interests declared.
  15. ANECS

    PO Royal Brisbane Hospital, Brisbane, Australia
    Competing interests
    No competing interests declared.
  16. Frederic Amant

    University Hospital Gasthuisberg, Leuven, Belgium
    Competing interests
    No competing interests declared.
  17. Diether Lambrechts

    VIB Vesalius Research Center, KU Leuven, Leuven, Belgium
    For correspondence
    diether.lambrechts@vib-kuleuven.be
    Competing interests
    Diether Lambrechts, an inventor on a patent application regarding the use of recurrent indels to detect MSI. The VIB is owner of this patent application, and the said patent application has been licensed to an outside company. Neither VIB nor any of the authors have equity stakes in the company. However, VIB stands to eventually receive royalties.

Ethics

Human subjects: Informed consent and consent to publish was obtained from all patients. Ethical approval was obtained at the ethical committee of University Hospital Gasthuisberg of Leuven with identifier ML2266.

Copyright

© 2014, Zhao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,384
    views
  • 1,028
    downloads
  • 70
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hui Zhao
  2. Bernard Thienpont
  3. Betül T Yesilyurt
  4. Matthieu Moisse
  5. Joke Reumers
  6. Lieve Coenegrachts
  7. Xavier Sagaert
  8. Stefanie Schrauwen
  9. Dominiek Smeets
  10. Gert Matthijs
  11. Stein Aerts
  12. Jan Cools
  13. Alex Metcalf
  14. Amanda Spurdle
  15. ANECS
  16. Frederic Amant
  17. Diether Lambrechts
(2014)
Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks
eLife 3:e02725.
https://doi.org/10.7554/eLife.02725

Share this article

https://doi.org/10.7554/eLife.02725

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Jia-Ying Su, Yun-Lin Wang ... Chien-Ling Lin
    Research Article

    Untranslated regions (UTRs) contain crucial regulatory elements for RNA stability, translation and localization, so their integrity is indispensable for gene expression. Approximately 3.7% of genetic variants associated with diseases occur in UTRs, yet a comprehensive understanding of UTR variant functions remains limited due to inefficient experimental and computational assessment methods. To systematically evaluate the effects of UTR variants on RNA stability, we established a massively parallel reporter assay on 6555 UTR variants reported in human disease databases. We examined the RNA degradation patterns mediated by the UTR library in two cell lines, and then applied LASSO regression to model the influential regulators of RNA stability. We found that UA dinucleotides and UA-rich motifs are the most prominent destabilizing element. Gain of UA dinucleotide outlined mutant UTRs with reduced stability. Studies on endogenous transcripts indicate that high UA-dinucleotide ratios in UTRs promote RNA degradation. Conversely, elevated GC content and protein binding on UA dinucleotides protect high-UA RNA from degradation. Further analysis reveals polarized roles of UA-dinucleotide-binding proteins in RNA protection and degradation. Furthermore, the UA-dinucleotide ratio of both UTRs is a common characteristic of genes in innate immune response pathways, implying a coordinated stability regulation through UTRs at the transcriptomic level. We also demonstrate that stability-altering UTRs are associated with changes in biobank-based health indices, underscoring the importance of precise UTR regulation for wellness. Our study highlights the importance of RNA stability regulation through UTR primary sequences, paving the way for further exploration of their implications in gene networks and precision medicine.

    1. Genetics and Genomics
    Angela M Tuckowski, Safa Beydoun ... Scott F Leiser
    Research Article

    Flavin-containing monooxygenases (FMOs) are a conserved family of xenobiotic enzymes upregulated in multiple longevity interventions, including nematode and mouse models. Previous work supports that C. elegans fmo-2 promotes longevity, stress resistance, and healthspan by rewiring endogenous metabolism. However, there are five C. elegans FMOs and five mammalian FMOs, and it is not known whether promoting longevity and health benefits is a conserved role of this gene family. Here, we report that expression of C. elegans fmo-4 promotes lifespan extension and paraquat stress resistance downstream of both dietary restriction and inhibition of mTOR. We find that overexpression of fmo-4 in just the hypodermis is sufficient for these benefits, and that this expression significantly modifies the transcriptome. By analyzing changes in gene expression, we find that genes related to calcium signaling are significantly altered downstream of fmo-4 expression. Highlighting the importance of calcium homeostasis in this pathway, fmo-4 overexpressing animals are sensitive to thapsigargin, an ER stressor that inhibits calcium flux from the cytosol to the ER lumen. This calcium/fmo-4 interaction is solidified by data showing that modulating intracellular calcium with either small molecules or genetics can change expression of fmo-4 and/or interact with fmo-4 to affect lifespan and stress resistance. Further analysis supports a pathway where fmo-4 modulates calcium homeostasis downstream of activating transcription factor-6 (atf-6), whose knockdown induces and requires fmo-4 expression. Together, our data identify fmo-4 as a longevity-promoting gene whose actions interact with known longevity pathways and calcium homeostasis.